Stock Track | Clearwater Analytics Stock Soars 8.95% After-Hours on Strong Q4 Results and 2025 Outlook

Stock Track
20 Feb

Clearwater Analytics Holdings, Inc. (CWAN) stock surged 8.95% in after-hours trading on Wednesday, following the company's impressive fourth quarter 2024 results and optimistic outlook for 2025.

The financial technology company reported record quarterly revenue of $126.5 million, up 27.7% year-over-year, surpassing analysts' expectations. Clearwater's non-GAAP diluted earnings per share of $0.13 also exceeded estimates, marking a 30% increase from the same period last year.

Driving Clearwater's robust performance was strong demand for its investment management solutions, as reflected in the 25.3% year-over-year growth in annualized recurring revenue (ARR) to $474.9 million. The company also achieved a record net revenue retention rate of 116%, highlighting its ability to expand within its existing client base.

Looking ahead, Clearwater provided an optimistic outlook for 2025, forecasting revenue of $535.5 million to $542 million, representing a 19% to 20% year-over-year growth. The company expects adjusted EBITDA margins to expand to around 34% for the full year, underscoring its profitability improvements.

Investors were further enthused by Clearwater's recent announcement of its intent to acquire Enfusion, Inc. for $1.5 billion, expanding its platform with front-to-back capabilities for the investment management industry.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10